Total
0
Shares
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • ShaMaran Petroleum (SNM) has received C$32.1 million in Atrush sales and entitlements for August 2021
  • This includes $11.8 million net to the company
  • It also received $1.97 million net as the next instalment for August 2021 in the Kurdistan Regional Government’s receivable repayment mechanism
  • CEO Adel Chaouch sat down with Caroline Egan to provide further insights into the news
  • ShaMaran is a Kurdistan-focused oil development and exploration company which holds a 27.6-per-cent interest in the Atrush Block production sharing contract
  • ShaMaran Petroleum (SNM) is down by 6.25 per cent and is currently trading at $0.075 per share

ShaMaran Petroleum (SNM) has received C$32.1 million in Atrush sales and entitlements for August 2021.

This includes $11.8 million net to the company.

Today’s payment reduces the Kurdistan Regional Government’s (KRG) amount owed to ShaMaran to $25.92 million.

ShaMaran also received $1.97 million net as the next instalment for August 2021 in the KRG’s receivable repayment mechanism.

The company continues to facilitate discussions with the KRG on its proposed amendment to the repayment terms as announced on May 13, 2021.

Our Caroline Egan sat down with CEO Adel Chaouch to discuss past production history, potential acquisitions and the company’s partnership with the Kurdistan Government moving forward.

ShaMaran is a Kurdistan-focused oil development and exploration company that holds a 27.6-per-cent interest in the Atrush Block production sharing contract.

ShaMaran Petroleum (SNM) is down by 6.25 per cent and is currently trading at $0.075 per share as of 1:01 pm ET.

More From The Market Herald
The Market Herald Video

" LUXXFOLIO Holdings (CSE:LUXX) provides operational update

LUXXFOLIO Holdings’ (LUXX) November updates includes record mining revenues of approximately $1.8 million and monthly rewards of 23.5 Bitcoin.
The Market Herald Video

" FSD Pharma (CSE:HUGE) demonstrates positive effects of Lucid-MS in treating MS in pre-clinical models

FSD Pharma (HUGE) is sharing pre-clinical data demonstrating the potentially disease-modifying effects of its lead drug candidate Lucid-MS.
The Market Herald Video

" Baselode Energy (TSXV:FIND) closes $9.2M private placement

Baselode Energy (FIND) has closed its “bought deal” private placement for aggregate proceeds of $9,200,632.50, including the exercise of the over-allotment option.
The Market Herald Video

" Railtown AI Technologies (CSE:RAIL) announces CSE listing

Railtown AI Technologies (RAIL)  has completed its prospectus offering and listing on the Canadian Stock Exchange.